Immunity to heat shock proteins and arthritic disorders.

Infect Dis Obstet Gynecol. 1999; 7(1-2): 49–54.

PMCID: PMC1784715

W van Eden

Institute of Infectious Diseases and Immunology, Utrecht University, The Netherlands.

W van Eden: w.eden/at/vet.uu.nl

This article has been cited by other articles in PMC.

Abstract

Adjuvant arthritis (AA) is a frequently used model of experimental arthritis. Because of its histopathology, which is reminiscent of rheumatoid arthritis in humans, AA is used as a model for the development of novel anti-inflammatory drugs. Recently, it has become evident that AA is a typical T-cell-mediated autoimmune condition. Therefore, novel immunotherapies targeted to T cells can be developed in this model. Analysis of responding T cells in AA have now led to the definition of various antigens with potential relevance to arthritis, including human arthritic conditions. One such antigen defined in AA is the 60kD heat shock protein. Both T-cell vaccination approaches and active antigen immunizations and antigen toleration approaches have turned out to be effective in suppressing AA.

Full Text

The Full Text of this article is available as a PDF (553K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Holoshitz, J; Naparstek, Y; Ben-Nun, A; Cohen, IR. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science. 1983 Jan 7;219(4580):56–58. [PubMed]
van Eden, W; Holoshitz, J; Nevo, Z; Frenkel, A; Klajman, A; Cohen, IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5117–5120. [PubMed]
Prakken, B; Wauben, M; van Kooten, P; Anderton, S; van der Zee, R; Kuis, W; van Eden, W. Nasal administration of arthritis-related T cell epitopes of heat shock protein 60 as a promising way for immunotherapy in chronic arthritis. Biotherapy. 1998;10(3):205–211. [PubMed]
van Eden, W; Thole, JE; van der Zee, R; Noordzij, A; van Embden, JD; Hensen, EJ; Cohen, IR. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 1988 Jan 14;331(6152):171–173. [PubMed]
van den Broek, MF; Hogervorst, EJ; Van Bruggen, MC; Van Eden, W; van der Zee, R; van den Berg, WB. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med. 1989 Aug 1;170(2):449–466. [PubMed]
Billingham, ME; Carney, S; Butler, R; Colston, MJ. A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med. 1990 Jan 1;171(1):339–344. [PubMed]
Thompson, SJ; Elson, CJ. Susceptibility to pristane-induced arthritis is altered with changes in bowel flora. Immunol Lett. 1993 May;36(2):227–231. [PubMed]
Anderton, SM; van der Zee, R; Noordzij, A; van Eden, W. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol. 1994 Apr 1;152(7):3656–3664. [PubMed]
Anderton, SM; van der Zee, R; Prakken, B; Noordzij, A; van Eden, W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med. 1995 Mar 1;181(3):943–952. [PubMed]
Boog, CJ; de Graeff-Meeder, ER; Lucassen, MA; van der Zee, R; Voorhorst-Ogink, MM; van Kooten, PJ; Geuze, HJ; van Eden, W. Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med. 1992 Jun 1;175(6):1805–1810. [PubMed]
Wilbrink, B; Holewijn, M; Bijlsma, JW; van Roy, JL; den Otter, W; van Eden, W. Suppression of human cartilage proteoglycan synthesis by rheumatoid synovial fluid mononuclear cells activated with mycobacterial 60-kd heat-shock protein. Arthritis Rheum. 1993 Apr;36(4):514–518. [PubMed]
SILVERSTONE, FA; BRANDFONBRENER, M; SHOCK, NW; YIENGST, MJ. Age differences in the intravenous glucose tolerance tests and the response to insulin. J Clin Invest. 1957 Mar;36(3):504–514. [PubMed]
Prakken, AB; van Hoeij, MJ; Kuis, W; Kavelaars, A; Heynen, CJ; Scholtens, E; de Kleer, IM; Rijkers, GT; van Eden, W. T-cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint. Immunol Lett. 1997 Jun 1;57(1-3):139–142. [PubMed]
Prakken, AB; van Eden, W; Rijkers, GT; Kuis, W; Toebes, EA; de Graeff-Meeder, ER; van der Zee, R; Zegers, BJ. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 1996 Nov;39(11):1826–1832. [PubMed]
van Roon, JA; van Eden, W; van Roy, JL; Lafeber, FJ; Bijlsma, JW. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest. 1997 Jul 15;100(2):459–463. [PubMed]
Kohashi, O; Kohashi, Y; Takahashi, T; Ozawa, A; Shigematsu, N. Suppressive effect of Escherichia coli on adjuvant-induced arthritis in germ-free rats. Arthritis Rheum. 1986 Apr;29(4):547–553. [PubMed]
Vischer, TL; Van Eden, W. Oral desensitisation in rheumatoid arthritis. Ann Rheum Dis. 1994 Nov;53(11):708–710. [PubMed]
Bloemendal, A; Van der Zee, R; Rutten, VP; van Kooten, PJ; Farine, JC; van Eden, W. Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA). Clin Exp Immunol. 1997 Oct;110(1):72–78. [PubMed]
Taams, LS; van Rensen, AJ; Poelen, MC; van Els, CA; Besseling, AC; Wagenaar, JP; van Eden, W; Wauben, MH. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol. 1998 Sep;28(9):2902–2912. [PubMed]
Rosenthal, M; Bahous, I; Ambrosini, G. Longterm treatment of rheumatoid arthritis with OM-8980. A retrospective study. J Rheumatol. 1991 Dec;18(12):1790–1793. [PubMed]
Bonnin, D; Albani, S. Mucosal modulation of immune responses to heat shock proteins in autoimmune arthritis. Biotherapy. 1998;10(3):213–221. [PubMed]
van Eden, W; van der Zee, R; Paul, AG; Prakken, BJ; Wendling, U; Anderton, SM; Wauben, MH. Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today. 1998 Jul;19(7):303–307. [PubMed]